TCR Activator - CHO Recombinant Cell line
8218.88 €
In Stock
quantity
product details
Catalog number: 421 - 60539
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 2 vials
60548
CD155 / TCR Activator - CHO Recombinant Cell line
Recombinant CHO-K1 cells constitutively expressing human CD155 (Poliovirus receptor, Nectin-like protein 5, GenBank accession #NM_006505) and an engineered T cell receptor (TCR) activator.
16596.83 €
78436
TCR Activator/FcGR2B CHO Cell Line
Recombinant clonal CHO-K1 cells stably expressing a membrane bound, engineered TCR (T-cell receptor) activator and human FcGR2B (Fc gamma receptor IIb, NM #004001). The cells were generated from the TCR Activator CHO Cell Line (BPS Bioscience #60539).
15816.60 €
79632
PD-L2 / TCR activator - CHO Recombinant Cell Line
Recombinant CHO-K1 cells constitutively expressing human PD-L2 (Programmed Cell Death 1 Ligand 2 or CD273, GenBank accession #NM_025239) and an engineered T-cell receptor (TCR) activator.
14392.50 €
79557-M
CD22 CHO Recombinant Cell Line (Medium Expression)
Recombinant clonal stable CHO cell line constitutively expressing full length human CD22 protein (Genbank #NM_001771). Surface expression of CD22 was confirmed by flow cytometry. This clonal cell line was selected for medium level expression of CD22. A clone exhibiting higher levels of CD22 expression is also available (#79557-H). Please contact BPS Bioscience for additional information.
10983.75 €
79561-H
CD19 CHO Recombinant Cell Line (High Expression)
Recombinant clonal stable CHO cell line constitutively expressing full length human CD19 protein, also known as B4 or CVID3, (Genbank #NM_001770). Surface expression of CD19 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD19 expression (High, Medium, Low) to mimic different stages of cancer target cells with various CD19 expression levels.
10983.75 €
79561-L
CD19 CHO Recombinant Cell Line (Low Expression)
Recombinant clonal stable CHO cell line constitutively expressing full length human CD19 protein, also known as B4 or CVID3, (Genbank #NM_001770). Surface expression of CD19 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD19 expression (High, Medium, Low) to mimic different stages of cancer target cells with various CD19 expression levels.